Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 33,750 | 9,122 | 17,851 | 15,658 | 10,113 |
| Cost of Goods | 4,127 | 4,619 | 8,324 | 5,870 | 8,180 |
| Gross Profit | 29,623 | 4,503 | 9,527 | 9,788 | 1,933 |
| Operating Expenses | 8,604 | 9,780 | 7,720 | 9,486 | 6,258 |
| Operating Income | 21,146 | -4,658 | 2,131 | 1,172 | -4,145 |
| Other Income | -5 | -118 | 108 | -511 | 413 |
| Pre-tax Income | 21,141 | -4,776 | 2,239 | 661 | -3,732 |
| Income Tax | 2,824 | 728 | -116 | 497 | -113 |
| Net Income Continuous | 18,317 | -5,504 | 2,355 | 164 | -3,619 |
| Net Income | $18,317 | $-5,504 | $2,355 | $164 | $-3,619 |
| EPS Basic Total Ops | 0.23 | -0.06 | 0.03 | 0.00 | -0.05 |
| EPS Basic Continuous Ops | 0.23 | -0.07 | 0.03 | 0.00 | -0.05 |
| EPS Diluted Total Ops | 0.22 | -0.06 | 0.03 | 0.00 | -0.05 |
| EPS Diluted Continuous Ops | 0.22 | -0.07 | 0.03 | 0.00 | -0.05 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.07 | 0.03 | 0.00 | -0.05 |
| EBITDA(a) | $21,550 | $-4,271 | $2,503 | $1,532 | $-3,799 |